You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201791 - 201800 of 207712 results
  1. Evaluation of a low-fluoride anticaries toothpaste containing an innovative calci

    SBC: Indiana Nanotech, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A recent clinical research report on children found that over a two-year period although there was no statistical differences in anticaries benefits between two groups using either 1000 ppm F or 400 to 550 ppm F toothpastes, there was a directional trend of caries incidence increasing with lower fluoride toothpastes. Nevertheless clinical data demonstrate carie ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. GENE EXPRESSION EXON ARRAY BIOMARKERS TO DIAGNOSE SCHIZOPHRENIA

    SBC: ABASTAR MDX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): AbaStar MDx RFA-OD-09-009, (R43), SBIR - Gene Expression Exon Array Biomarkers to Diagnose Schizophrenia Project Summary/Abstract This application RFA-OD-09-009, addresses Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43). The proposal is titled: Gene Expression Exon Array Biomarkers to Diagnose Schizop ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  3. Customized Pharmaceutical Membranes for Fine Crystal Size Control

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Project Summary/Abstract The objective of this program is to build a platform technology based on developing membrane-crystallization technology to produce crystals of active pharmaceutical ingredients in which the crystal size and crystal form polymorph or pseudo-polymorph are controlled. Control of crystal size within a narrow range is an important part o ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Stability and functionality of the Immunoject single-dose, auto-reconstitution de

    SBC: AKTIV-DRY            Topic: N/A

    DESCRIPTION (provided by applicant): Assuring the success of mass campaigns against bioterrorist or naturally occurring pathogens requires that vaccines, therapeutics, and other products are stored and ready for immediate use at the time the threat to public health is perceived. Storage is a major contributor to the cost of administration under these circumstances and a requirement to keep the act ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  5. Disposable Instrument for Broader Patient Access to Vision Restoration Therapy

    SBC: Ocular Transplantation LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Retinal diseases such as age-related macular degeneration (AMD), retinal dystrophies, and retinitis pigmentosa (RP) affect millions of Americans. As the population ages, this number will grow significantly. Many people will lose their sight due to degeneration of photoreceptors and/or retinal pigment epithelium (RPE). The majority of clinical studies performed ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Development of Bacterial Therapeutics Targeting Bacterial Vaginosis-Associated Bi

    SBC: OSEL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This application focuses on the development of a novel bacterial therapeutics targeting bacterial vaginosis (BV)-associated biofilm for the prevention and treatment of recurrent BV using a novel strain of Lactobacillus jensenii with a disrupted pox1 gene in the chromosome that exhibits highly potent activity against a Gardnerella vaginalis strain (ATCC 14018). ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Using a Biomarker Panel for Detecting Adolescent Depression

    SBC: PRECISION HUMAN BIOLABORATORY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 6% of all U.S. teenagers suffer from clinical depression which is known to result in continued risk for recurrences with persistence of depressive episodes and psychosocial morbidity into adulthood. MDD can have a serious impact on the lives of teens, by way of example: untreated depression is the number one cause of suicide, which is the third le ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  8. Multi-plexed Cardiac Biomarker Detection Using Electrochemically Active Aptamers

    SBC: INNOSENSE CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Heart disease surpasses cancer as the leading cause of death in the United States. To better diagnose cardiovascular diseases and to accurately evaluate patient risk for such life- threatening conditions, ISL's Phase I efforts will focus on the characterization of microelectrodes modified with a trimolecular SAM and the ability of the modified electrodes to p ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  9. Resorbable Small Diameter Vascular Grafts

    SBC: Spectrasilk, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): This application entitled Development, Characterization, and Application of Multifunctional Antithrombogenic Silk Grafts, is a response to the Request for Applications (RFA) number RFA-OD- 09-009: Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43). In this proposal, we seek to accelerate transitions to ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  10. Novel SCID rat models for human cell transplantation studies

    SBC: TRANSPOSAGEN BIOPHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The laboratory rat is used extensively by the pharmaceutical industry for preclinical animal efficacy and toxicology studies. In addition, the rat has been a valuable animal model for physiology, behavior, and pharmacology research programs, due to ease of experimental manipulation. Their larger size facilitates procedures otherwise difficult in mice, including ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government